Browse the evidence

Late-afternoon resistance training elicits greater hypertrophy and strength adaptations than morning training due to a higher exercise-induced testosterone response, despite higher baseline morning testosterone levels.

If your goal is maximizing muscle growth and strength, schedule your heavy resistance training sessions for the late afternoon (e.g., 4 PM - 8 PM). While your testosterone is naturally higher in the morning, your body's hormonal response to the stress of lifting weights is significantly greater in the late afternoon, leading to better long-term gains. Avoid morning training if you can, as high morning cortisol may blunt the anabolic benefits of morning testosterone.

Repeated morning resistance training can blunt the typical diurnal variation in strength performance, effectively increasing morning strength to match afternoon levels.

If you are forced to train in the morning due to schedule constraints, do not worry about the 'afternoon peak' myth. Consistent morning training will adapt your body, increasing your morning strength to levels comparable to the afternoon. The key is consistency; your body will adjust its circadian strength rhythm to match your training schedule.

Administration of 3 g American ginseng (Panax quinquefolius) reduces postprandial glycemia in type 2 diabetic individuals, with no significant additional benefit from escalating the dose to 6 g or 9 g.

If you have Type 2 Diabetes, take 3 grams of American ginseng (Panax quinquefolius) either with your meal or up to 2 hours before it to significantly blunt your blood sugar spike. You do not need to take higher doses (6g or 9g) for better results, nor do you need to worry about the exact timing as long as it is within that 2-hour window. It will not cause low blood sugar on its own.

In older adults (aged 50+), lower serum 25-hydroxyvitamin D levels are significantly associated with a higher risk of sarcopenia, independent of obesity and other lifestyle factors.

If you are over 50, ensuring adequate Vitamin D levels may help protect against muscle loss (sarcopenia). This study links higher Vitamin D levels with lower sarcopenia risk, independent of weight. Consult a doctor to check your levels, as deficiency is common and potentially modifiable.

In older men with diabetes, treatment with insulin sensitizers (metformin and/or thiazolidinediones) significantly attenuates the accelerated loss of total and appendicular lean mass compared to untreated diabetes or diabetes treated without insulin sensitizers.

If you are an older man with diabetes, ask your doctor if your current medication is an 'insulin sensitizer' like metformin or a thiazolidinedione. This study suggests these drugs may help protect your muscle mass from the accelerated loss often seen in diabetes. If you are not on one, or are on other diabetes meds, discuss whether switching to or adding an insulin sensitizer might help preserve your strength and mobility.

Resistance training (RT) and endurance training (ET) modulate distinct biochemical pathways to counteract sarcopenia, with RT primarily promoting net muscle protein anabolism and ET improving mitochondrial biogenesis and aerobic capacity.

To combat age-related muscle loss, older adults should engage in a balanced program of both resistance and endurance exercises. For resistance training, aim for at least two days per week, performing 8-12 repetitions of exercises targeting major muscle groups. Use a moderate to vigorous intensity (RPE 5-8). If joint stress is a concern, consider aquatic exercise or stationary cycling. Consistency is key, as both types of exercise have been shown to improve muscle strength, mitochondrial function, and overall muscle health.

Weight loss achieved through primary care interventions, whether pharmacologic or lifestyle-based, significantly attenuates over time, with an average regain of 0.53 kg per six months.

Do not expect your initial weight loss to stick if you stop the intervention. The body fights back against weight loss through hormonal changes. To maintain weight loss, you likely need to continue the intervention (medication or intensive lifestyle support) long-term, rather than treating it as a finite 'course'.

Insulin stimulates muscle sympathetic nerve activity, which contributes to 'facultative thermogenesis' (energy expenditure beyond obligatory ATP hydrolysis), particularly in response to glucose and fructose.

This is a complex physiological mechanism. For practical purposes, high insulin levels (from high carb intake) may slightly increase energy expenditure via sympathetic activation, but this is not a reliable weight loss strategy.

High-fat diets disrupt circadian clock gene expression and desynchronize peripheral clocks from the central pacemaker, leading to metabolic disorders such as obesity and insulin resistance, regardless of total caloric intake or obesity development.

Your internal biological clock is sensitive to what you eat, not just how much. High-fat diets can disrupt the timing of your metabolic genes, leading to insulin resistance and weight gain even without overeating. To support metabolic health, prioritize balanced nutrient intake and consider the timing of your meals, especially fat consumption, to align with your body's natural rhythms.

Glucose and insulin act as entraining signals for peripheral clocks, and disruptions in glucose/insulin signaling (e.g., insulin resistance) can alter circadian gene expression in the liver.

Maintaining stable blood glucose and insulin levels through a balanced diet may support healthy circadian rhythms in your liver. Avoiding large spikes in blood sugar could help keep your metabolic clock running smoothly.

Omega-3 fatty acid supplementation does not enhance muscle protein synthesis in young men who are already consuming adequate protein and performing resistance exercise.

If you are a young man who eats enough protein and lifts weights, adding high-dose omega-3s (5g/day) likely won't give you extra muscle protein synthesis benefits beyond what you're already getting.

Women in urban East African settings exhibit significantly higher prevalence of obesity, abdominal adiposity, and metabolic syndrome compared to men, despite having lower odds of hypertension.

In this specific population, women face a disproportionately high risk of metabolic syndrome and obesity compared to men, even if their blood pressure remains lower. Prevention strategies should prioritize weight management and metabolic screening for women, addressing cultural perceptions of body image that may discourage weight loss efforts.

Interleukin-6 (IL-6) signaling via the JAK2/STAT3 pathway acts as a critical autocrine regulator of human muscle satellite cell (SC) proliferation following acute muscle-damaging exercise.

To maximize muscle growth, you need to trigger the satellite cell response. This paper shows that muscle-damaging exercise (like eccentric contractions) spikes IL-6, which activates the JAK2/STAT3 pathway in satellite cells, driving them to proliferate. Don't fear the soreness or inflammation; it's the biological signal telling your muscle stem cells to activate and repair. Ensure you are recovering adequately to allow this proliferation to occur.

GLP-1 receptor agonists (GLP-1RA) are associated with a disproportionate reporting signal for specific neoplasms, particularly medullary thyroid cancer (MTC), papillary thyroid cancer (PTC), and pancreatic neoplasms, whereas overall tumor risk is not significantly increased.

GLP-1 receptor agonists do not increase the overall risk of cancer, but they are associated with specific, high-magnitude signals for medullary thyroid cancer (MTC), papillary thyroid cancer (PTC), and pancreatic neoplasms. Clinicians should maintain vigilance, particularly when combining GLP-1RA with DPP4 inhibitors, which may further increase reporting rates for these specific tumors. The benefits of GLP-1RA for cardiovascular and metabolic health remain significant, but patients with a history of MTC or pancreatitis should be carefully evaluated.

High-glycemic load carbohydrates drive obesity through calorie-independent hormonal mechanisms (specifically insulin-mediated fat storage and reduced energy expenditure) rather than solely through excess caloric intake.

Focus on reducing the glycemic load of your diet by minimizing refined carbohydrates, sugars, and processed grains. This approach addresses the hormonal drivers of fat storage (insulin) and energy partitioning, rather than relying solely on calorie restriction which may trigger metabolic slowdown and hunger.

Neurotensin (Nts) neurons in the LHA are implicated in coordinating anorectic stimuli and behavior to regulate hydration and energy balance.

Neurotensin neurons in the LHA are emerging as important regulators of hydration and energy balance. Further research is needed to fully understand their role and potential therapeutic applications.

Mendelian randomization studies suggest that genetic predisposition to MASLD via impaired VLDL secretion (PNPLA3, TM6SF2) may lower plasma lipids and potentially reduce coronary artery disease risk, whereas other MASLD genes show weak or no association with CAD.

This is a mechanistic insight rather than a direct intervention. It suggests that the way some people develop liver fat (by not secreting VLDL efficiently) might paradoxically protect them from heart disease. This highlights the complexity of the liver-heart axis.

Acute ingestion of 10 mg purified capsinoids increases resting energy expenditure and shifts substrate utilization toward lipid oxidation, but these effects do not persist during moderate-intensity exercise.

Take 10 mg of purified capsinoids (containing capsiate, dihydrocapsiate, and norhydrocapsiate) on an empty stomach, ideally 30 minutes before you sit down for work or rest, not before your workout. This specific dose has been shown to increase your resting calorie burn by about 20% and shift your body to burn more fat for fuel while you are inactive. Do not expect this to enhance your exercise performance or fat burning during the activity itself, as the metabolic boost from the exercise itself overrides the supplement's effect.

Exposure to environmental obesogens (e.g., BPA, PFAS, pesticides) during critical developmental windows programs long-term metabolic dysfunction by hijacking redox signaling (ROS) and endocrine pathways, leading to increased adiposity and insulin resistance later in life.

To mitigate the impact of obesogens, prioritize reducing exposure to environmental chemicals that disrupt hormonal and redox signaling. This includes choosing fresh foods over ultra-processed items (which may contain obesogenic additives or packaging leachates), filtering drinking water, and minimizing the use of plastics (especially for heating food) and harsh household cleaners. While diet and exercise remain important, recognizing the role of environmental factors suggests that reducing exposure to these chemicals is a critical, often overlooked component of obesity prevention.

Use of GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) is associated with a low incidence (1.18%) of psychiatric adverse events, including depression, anxiety, and suicidal ideation, with a small but significant number of fatal outcomes.

If you are taking semaglutide, liraglutide, or tirzepatide, be aware that mood changes like depression, anxiety, or suicidal thoughts are possible, though uncommon (approx 1%). Monitor your mental health closely. If you experience these symptoms, report them to your doctor immediately. Do not suffer in silence; early reporting helps manage safety risks.

Succinate signaling via the SUCNR1 receptor is required for strength gains from resistance training, as blocking this pathway compromises training-induced grip strength improvements despite enhancing endurance capacity.

For strength training, your body uses succinate signaling to build muscle and neural adaptations. You don't need to supplement succinate; just perform progressive resistance training. The paper suggests that if you were to block this specific pathway, you would lose strength gains, so ensure your training is consistent and progressive to naturally stimulate this mechanism.

Oral administration of the bis-lipidated GLP-1 receptor agonist MEDI7219 significantly reduces body weight and glucose excursions in a canine model of obesity and insulin resistance, demonstrating that peptide engineering and targeted delivery can overcome gastrointestinal barriers to achieve clinical efficacy.

This research validates a new class of oral GLP-1 drugs (like MEDI7219) that use specific engineering to survive digestion and absorb into the blood. In dogs, daily oral tablets successfully reduced weight and blood sugar. While human trials are not yet reported here, the mechanism suggests oral GLP-1s could eventually match injectables in efficacy while avoiding injections.

Serum from humans undergoing Alternate Day Fasting (ADF) induces in vitro cellular adaptations associated with longevity, including increased Sirt1 protein, reduced proliferation, and enhanced heat stress resistance.

If you practice Alternate Day Fasting, your body produces serum factors that may protect your cells from stress and aging markers like Sirt1. This suggests ADF is a potent tool for longevity, potentially more so than continuous mild restriction for some markers.

Serum from humans undergoing Continuous Calorie Restriction (CR) increases Sirt1 protein and PGC-1a mRNA levels in vitro, indicating metabolic and mitochondrial adaptations associated with longevity.

Continuous Calorie Restriction triggers cellular changes that support mitochondrial health and stress resistance. This suggests CR is effective for promoting longevity pathways, even if it doesn't always reduce proliferation as dramatically as ADF.